NO20003166D0 - Benzoksazin-forbindelser for forandring av synaptisk respons - Google Patents

Benzoksazin-forbindelser for forandring av synaptisk respons

Info

Publication number
NO20003166D0
NO20003166D0 NO20003166A NO20003166A NO20003166D0 NO 20003166 D0 NO20003166 D0 NO 20003166D0 NO 20003166 A NO20003166 A NO 20003166A NO 20003166 A NO20003166 A NO 20003166A NO 20003166 D0 NO20003166 D0 NO 20003166D0
Authority
NO
Norway
Prior art keywords
compounds
ampa receptors
change
disclosed
methods
Prior art date
Application number
NO20003166A
Other languages
English (en)
Other versions
NO20003166L (no
NO325764B1 (no
Inventor
Gary A Rogers
Christopher M Marrs
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO20003166D0 publication Critical patent/NO20003166D0/no
Publication of NO20003166L publication Critical patent/NO20003166L/no
Publication of NO325764B1 publication Critical patent/NO325764B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20003166A 1997-12-24 2000-06-19 Benzoksazin-forbindelser for forandring av synaptisk respons NO325764B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/998,300 US5985871A (en) 1997-12-24 1997-12-24 Benzoxazine compounds for enhancing synaptic response
PCT/US1998/027027 WO1999033469A1 (en) 1997-12-24 1998-12-16 Benzoxazine compounds for enhancing synaptic response

Publications (3)

Publication Number Publication Date
NO20003166D0 true NO20003166D0 (no) 2000-06-19
NO20003166L NO20003166L (no) 2000-08-07
NO325764B1 NO325764B1 (no) 2008-07-14

Family

ID=25545024

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003166A NO325764B1 (no) 1997-12-24 2000-06-19 Benzoksazin-forbindelser for forandring av synaptisk respons

Country Status (22)

Country Link
US (1) US5985871A (no)
EP (1) EP1054673B1 (no)
JP (1) JP4620244B2 (no)
KR (1) KR100561049B1 (no)
CN (1) CN1160360C (no)
AT (1) ATE261306T1 (no)
AU (1) AU746971B2 (no)
BR (1) BR9814478A (no)
CA (1) CA2316356C (no)
DE (1) DE69822344T2 (no)
DK (1) DK1054673T3 (no)
ES (1) ES2217615T3 (no)
HU (1) HUP0102056A3 (no)
IL (1) IL136783A (no)
MX (1) MXPA00006155A (no)
NO (1) NO325764B1 (no)
NZ (1) NZ505212A (no)
PL (1) PL194905B1 (no)
PT (1) PT1054673E (no)
RU (1) RU2246497C2 (no)
TR (1) TR200001971T2 (no)
WO (1) WO1999033469A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110935A (en) 1997-02-13 2000-08-29 The Regents Of The University Of California Benzofurazan compounds for enhancing glutamatergic synaptic responses
US6124278A (en) * 1998-04-03 2000-09-26 The Regents Of The University Of California Acylbenzoxazines for enhancing synaptic response
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
TWI232863B (en) 2001-06-11 2005-05-21 Akzo Nobel Nv Benzoxazepine derivatives
KR100864267B1 (ko) 2001-06-14 2008-10-20 엔.브이.오가논 ＡＭＰＡ 수용체의 양성 조절제로서의(피리도/티에노)-[ｆ]-옥사제핀-5-온 유도체
KR20050094840A (ko) 2003-01-13 2005-09-28 코텍스 파마슈티칼스, 인크. 수면 부족 및 스트레스로 인한 인식 저하의 치료방법
WO2006034196A1 (en) * 2004-09-17 2006-03-30 Lifelike Biomatic Inc. Compositions for enhancing memory and methods therefor
GEP20125438B (en) * 2007-01-03 2012-03-26 Servier Lab 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses
BRPI0720323A2 (pt) * 2007-01-03 2016-08-09 Cortex Pharma Inc composto, método de tratamento, composição farmacêutica e uso do composto
WO2008143963A1 (en) 2007-05-17 2008-11-27 Cortex Pharmaceuticals, Inc. Di-substituted amides for enhancing glutamatergic synaptic responses
US8119632B2 (en) 2007-08-10 2012-02-21 Cortex Pharmaceuticals, Inc. Bicyclic amide derivatives for enhancing glutamatergic synaptic responses
CA2695742C (en) 2007-08-10 2012-11-27 Rudolf Mueller Bicyclic amides for enhancing glutamatergic synaptic responses
WO2010054336A2 (en) * 2008-11-10 2010-05-14 The Regents Of The University Of California Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
US20130058915A1 (en) 2010-03-02 2013-03-07 Children's Medica Center Corporation Methods and compositions for treatment of angelman syndrome and autism spectrum disorders
EP2801377B1 (en) 2011-03-04 2019-08-07 The Regents of The University of California Hydrogel comprising cells for local release of growth factors to mediate motor recovery after stroke
KR101658274B1 (ko) * 2011-04-06 2016-09-22 다이호야쿠힌고교 가부시키가이샤 신규 이미다조 옥사진 화합물 또는 그의 염
EP3008167A4 (en) 2013-06-13 2017-06-07 VeroScience LLC Compositions and methods for treating metabolic disorders
EP3436021A4 (en) 2016-03-29 2019-11-06 RespireRx Pharmaceuticals Inc. COMPOSITIONS AND METHODS FOR TREATING ATTENTION DEFICIT DISORDER

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01207284A (ja) * 1987-10-06 1989-08-21 Takeda Chem Ind Ltd アミド化合物
EP0651746B1 (en) * 1992-07-24 2002-03-27 The Regents of the University of California Drugs that enhance synaptic responses mediated by ampa receptors
JPH0943929A (ja) * 1995-05-19 1997-02-14 Matsushita Electric Ind Co Ltd 電子写真複写装置
US5650409A (en) * 1995-06-02 1997-07-22 Cortex Pharmaceuticals, Inc. Benzoyl piperidines/pyrrolidines for enhancing synaptic response
US5736543A (en) * 1996-04-03 1998-04-07 The Regents Of The University Of California Benzoxazines for enhancing synaptic response

Also Published As

Publication number Publication date
EP1054673B1 (en) 2004-03-10
AU746971B2 (en) 2002-05-09
WO1999033469A1 (en) 1999-07-08
PL341427A1 (en) 2001-04-09
CA2316356C (en) 2009-11-03
CN1160360C (zh) 2004-08-04
HUP0102056A3 (en) 2003-03-28
ATE261306T1 (de) 2004-03-15
NZ505212A (en) 2003-02-28
EP1054673A1 (en) 2000-11-29
ES2217615T3 (es) 2004-11-01
RU2246497C2 (ru) 2005-02-20
PL194905B1 (pl) 2007-07-31
CN1283114A (zh) 2001-02-07
US5985871A (en) 1999-11-16
JP4620244B2 (ja) 2011-01-26
JP2001527045A (ja) 2001-12-25
MXPA00006155A (es) 2002-04-24
PT1054673E (pt) 2004-08-31
EP1054673A4 (en) 2001-07-18
DE69822344T2 (de) 2005-02-17
CA2316356A1 (en) 1999-07-08
IL136783A0 (en) 2001-06-14
NO20003166L (no) 2000-08-07
KR100561049B1 (ko) 2006-03-16
IL136783A (en) 2005-11-20
KR20010033615A (ko) 2001-04-25
HUP0102056A2 (hu) 2001-11-28
TR200001971T2 (tr) 2001-01-22
DE69822344D1 (de) 2004-04-15
AU1930599A (en) 1999-07-19
DK1054673T3 (da) 2004-07-05
BR9814478A (pt) 2000-10-10
NO325764B1 (no) 2008-07-14

Similar Documents

Publication Publication Date Title
ATE226206T1 (de) Benzoxazine zur erhöhung der synaptischen reaktionen
NO20003166D0 (no) Benzoksazin-forbindelser for forandring av synaptisk respons
CA2138533A1 (en) Drugs that enhance synaptic responses mediated by ampa receptors
PT839134E (pt) Benzoilpiperidinas/pirrolidinas para melhoramento da resposta sinaptica
ID22342A (id) Senyawa benzofurazan yang meningkatakan kegiatan penerima ampa
NO20004383D0 (no) Acylbenzoksaziner til forbedring av synaptisk respons
EA200400584A1 (ru) Соединения карбонилбензоксазина для усиления глутаматергических синаптических ответов

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees